Global Latent TB Infection Testing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Latent TB Infection Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Latent TB Infection Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Latent TB Infection Testing market. Latent TB Infection Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Latent TB Infection Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Latent TB Infection Testing market.
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
Key Features:
The report on Latent TB Infection Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Latent TB Infection Testing market. It may include historical data, market segmentation by Type (e.g., Mantoux Test / Tuberculin Skin Test (TST), Interferon-Gamma Release Assay (IGRA)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Latent TB Infection Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Latent TB Infection Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Latent TB Infection Testing industry. This include advancements in Latent TB Infection Testing technology, Latent TB Infection Testing new entrants, Latent TB Infection Testing new investment, and other innovations that are shaping the future of Latent TB Infection Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Latent TB Infection Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Latent TB Infection Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Latent TB Infection Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Latent TB Infection Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Latent TB Infection Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Latent TB Infection Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Latent TB Infection Testing market.
Market Segmentation:
Latent TB Infection Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Latent TB Infection Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Latent TB Infection Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Latent TB Infection Testing market. Latent TB Infection Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Latent TB Infection Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Latent TB Infection Testing market.
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
Key Features:
The report on Latent TB Infection Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Latent TB Infection Testing market. It may include historical data, market segmentation by Type (e.g., Mantoux Test / Tuberculin Skin Test (TST), Interferon-Gamma Release Assay (IGRA)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Latent TB Infection Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Latent TB Infection Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Latent TB Infection Testing industry. This include advancements in Latent TB Infection Testing technology, Latent TB Infection Testing new entrants, Latent TB Infection Testing new investment, and other innovations that are shaping the future of Latent TB Infection Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Latent TB Infection Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Latent TB Infection Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Latent TB Infection Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Latent TB Infection Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Latent TB Infection Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Latent TB Infection Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Latent TB Infection Testing market.
Market Segmentation:
Latent TB Infection Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Mantoux Test / Tuberculin Skin Test (TST)
- Interferon-Gamma Release Assay (IGRA)
- Hospitals
- Public and Student Health
- Physician Offices and Clinics
- Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
- Pharmstandard (Generium Pharmaceutical)
- Sanofi S.A./Sanofi Pasteur Ltd.
- Statens Serum Institut (SSI)
- Autoimmun Diagnostika (AID) GmbH
- Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
- Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
- Immunoshop India Pvt. Ltd.
- Qiagen N.V.
- Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
- SD Biosensor, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Latent TB Infection Testing Market Size 2019-2030
2.1.2 Latent TB Infection Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Latent TB Infection Testing Segment by Type
2.2.1 Mantoux Test / Tuberculin Skin Test (TST)
2.2.2 Interferon-Gamma Release Assay (IGRA)
2.3 Latent TB Infection Testing Market Size by Type
2.3.1 Latent TB Infection Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
2.4 Latent TB Infection Testing Segment by Application
2.4.1 Hospitals
2.4.2 Public and Student Health
2.4.3 Physician Offices and Clinics
2.4.4 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
2.5 Latent TB Infection Testing Market Size by Application
2.5.1 Latent TB Infection Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
3 LATENT TB INFECTION TESTING MARKET SIZE BY PLAYER
3.1 Latent TB Infection Testing Market Size Market Share by Players
3.1.1 Global Latent TB Infection Testing Revenue by Players (2019-2024)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2019-2024)
3.2 Global Latent TB Infection Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LATENT TB INFECTION TESTING BY REGIONS
4.1 Latent TB Infection Testing Market Size by Regions (2019-2024)
4.2 Americas Latent TB Infection Testing Market Size Growth (2019-2024)
4.3 APAC Latent TB Infection Testing Market Size Growth (2019-2024)
4.4 Europe Latent TB Infection Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Latent TB Infection Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Latent TB Infection Testing Market Size by Country (2019-2024)
5.2 Americas Latent TB Infection Testing Market Size by Type (2019-2024)
5.3 Americas Latent TB Infection Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent TB Infection Testing Market Size by Region (2019-2024)
6.2 APAC Latent TB Infection Testing Market Size by Type (2019-2024)
6.3 APAC Latent TB Infection Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Latent TB Infection Testing by Country (2019-2024)
7.2 Europe Latent TB Infection Testing Market Size by Type (2019-2024)
7.3 Europe Latent TB Infection Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Latent TB Infection Testing by Region (2019-2024)
8.2 Middle East & Africa Latent TB Infection Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Latent TB Infection Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LATENT TB INFECTION TESTING MARKET FORECAST
10.1 Global Latent TB Infection Testing Forecast by Regions (2025-2030)
10.1.1 Global Latent TB Infection Testing Forecast by Regions (2025-2030)
10.1.2 Americas Latent TB Infection Testing Forecast
10.1.3 APAC Latent TB Infection Testing Forecast
10.1.4 Europe Latent TB Infection Testing Forecast
10.1.5 Middle East & Africa Latent TB Infection Testing Forecast
10.2 Americas Latent TB Infection Testing Forecast by Country (2025-2030)
10.2.1 United States Latent TB Infection Testing Market Forecast
10.2.2 Canada Latent TB Infection Testing Market Forecast
10.2.3 Mexico Latent TB Infection Testing Market Forecast
10.2.4 Brazil Latent TB Infection Testing Market Forecast
10.3 APAC Latent TB Infection Testing Forecast by Region (2025-2030)
10.3.1 China Latent TB Infection Testing Market Forecast
10.3.2 Japan Latent TB Infection Testing Market Forecast
10.3.3 Korea Latent TB Infection Testing Market Forecast
10.3.4 Southeast Asia Latent TB Infection Testing Market Forecast
10.3.5 India Latent TB Infection Testing Market Forecast
10.3.6 Australia Latent TB Infection Testing Market Forecast
10.4 Europe Latent TB Infection Testing Forecast by Country (2025-2030)
10.4.1 Germany Latent TB Infection Testing Market Forecast
10.4.2 France Latent TB Infection Testing Market Forecast
10.4.3 UK Latent TB Infection Testing Market Forecast
10.4.4 Italy Latent TB Infection Testing Market Forecast
10.4.5 Russia Latent TB Infection Testing Market Forecast
10.5 Middle East & Africa Latent TB Infection Testing Forecast by Region (2025-2030)
10.5.1 Egypt Latent TB Infection Testing Market Forecast
10.5.2 South Africa Latent TB Infection Testing Market Forecast
10.5.3 Israel Latent TB Infection Testing Market Forecast
10.5.4 Turkey Latent TB Infection Testing Market Forecast
10.5.5 GCC Countries Latent TB Infection Testing Market Forecast
10.6 Global Latent TB Infection Testing Forecast by Type (2025-2030)
10.7 Global Latent TB Infection Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Information
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business Overview
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Information
11.2.2 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pharmstandard (Generium Pharmaceutical) Main Business Overview
11.2.5 Pharmstandard (Generium Pharmaceutical) Latest Developments
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Information
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Main Business Overview
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Information
11.4.2 Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Statens Serum Institut (SSI) Main Business Overview
11.4.5 Statens Serum Institut (SSI) Latest Developments
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Information
11.5.2 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Autoimmun Diagnostika (AID) GmbH Main Business Overview
11.5.5 Autoimmun Diagnostika (AID) GmbH Latest Developments
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Information
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business Overview
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Information
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business Overview
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Information
11.8.2 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Immunoshop India Pvt. Ltd. Main Business Overview
11.8.5 Immunoshop India Pvt. Ltd. Latest Developments
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Information
11.9.2 Qiagen N.V. Latent TB Infection Testing Product Offered
11.9.3 Qiagen N.V. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Qiagen N.V. Main Business Overview
11.9.5 Qiagen N.V. Latest Developments
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Information
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business Overview
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments
11.11 SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Information
11.11.2 SD Biosensor, Inc. Latent TB Infection Testing Product Offered
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 SD Biosensor, Inc. Main Business Overview
11.11.5 SD Biosensor, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Latent TB Infection Testing Market Size 2019-2030
2.1.2 Latent TB Infection Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Latent TB Infection Testing Segment by Type
2.2.1 Mantoux Test / Tuberculin Skin Test (TST)
2.2.2 Interferon-Gamma Release Assay (IGRA)
2.3 Latent TB Infection Testing Market Size by Type
2.3.1 Latent TB Infection Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
2.4 Latent TB Infection Testing Segment by Application
2.4.1 Hospitals
2.4.2 Public and Student Health
2.4.3 Physician Offices and Clinics
2.4.4 Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
2.5 Latent TB Infection Testing Market Size by Application
2.5.1 Latent TB Infection Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
3 LATENT TB INFECTION TESTING MARKET SIZE BY PLAYER
3.1 Latent TB Infection Testing Market Size Market Share by Players
3.1.1 Global Latent TB Infection Testing Revenue by Players (2019-2024)
3.1.2 Global Latent TB Infection Testing Revenue Market Share by Players (2019-2024)
3.2 Global Latent TB Infection Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LATENT TB INFECTION TESTING BY REGIONS
4.1 Latent TB Infection Testing Market Size by Regions (2019-2024)
4.2 Americas Latent TB Infection Testing Market Size Growth (2019-2024)
4.3 APAC Latent TB Infection Testing Market Size Growth (2019-2024)
4.4 Europe Latent TB Infection Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Latent TB Infection Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Latent TB Infection Testing Market Size by Country (2019-2024)
5.2 Americas Latent TB Infection Testing Market Size by Type (2019-2024)
5.3 Americas Latent TB Infection Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent TB Infection Testing Market Size by Region (2019-2024)
6.2 APAC Latent TB Infection Testing Market Size by Type (2019-2024)
6.3 APAC Latent TB Infection Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Latent TB Infection Testing by Country (2019-2024)
7.2 Europe Latent TB Infection Testing Market Size by Type (2019-2024)
7.3 Europe Latent TB Infection Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Latent TB Infection Testing by Region (2019-2024)
8.2 Middle East & Africa Latent TB Infection Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Latent TB Infection Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LATENT TB INFECTION TESTING MARKET FORECAST
10.1 Global Latent TB Infection Testing Forecast by Regions (2025-2030)
10.1.1 Global Latent TB Infection Testing Forecast by Regions (2025-2030)
10.1.2 Americas Latent TB Infection Testing Forecast
10.1.3 APAC Latent TB Infection Testing Forecast
10.1.4 Europe Latent TB Infection Testing Forecast
10.1.5 Middle East & Africa Latent TB Infection Testing Forecast
10.2 Americas Latent TB Infection Testing Forecast by Country (2025-2030)
10.2.1 United States Latent TB Infection Testing Market Forecast
10.2.2 Canada Latent TB Infection Testing Market Forecast
10.2.3 Mexico Latent TB Infection Testing Market Forecast
10.2.4 Brazil Latent TB Infection Testing Market Forecast
10.3 APAC Latent TB Infection Testing Forecast by Region (2025-2030)
10.3.1 China Latent TB Infection Testing Market Forecast
10.3.2 Japan Latent TB Infection Testing Market Forecast
10.3.3 Korea Latent TB Infection Testing Market Forecast
10.3.4 Southeast Asia Latent TB Infection Testing Market Forecast
10.3.5 India Latent TB Infection Testing Market Forecast
10.3.6 Australia Latent TB Infection Testing Market Forecast
10.4 Europe Latent TB Infection Testing Forecast by Country (2025-2030)
10.4.1 Germany Latent TB Infection Testing Market Forecast
10.4.2 France Latent TB Infection Testing Market Forecast
10.4.3 UK Latent TB Infection Testing Market Forecast
10.4.4 Italy Latent TB Infection Testing Market Forecast
10.4.5 Russia Latent TB Infection Testing Market Forecast
10.5 Middle East & Africa Latent TB Infection Testing Forecast by Region (2025-2030)
10.5.1 Egypt Latent TB Infection Testing Market Forecast
10.5.2 South Africa Latent TB Infection Testing Market Forecast
10.5.3 Israel Latent TB Infection Testing Market Forecast
10.5.4 Turkey Latent TB Infection Testing Market Forecast
10.5.5 GCC Countries Latent TB Infection Testing Market Forecast
10.6 Global Latent TB Infection Testing Forecast by Type (2025-2030)
10.7 Global Latent TB Infection Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC)
11.1.1 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Company Information
11.1.2 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered
11.1.3 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business Overview
11.1.5 Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments
11.2 Pharmstandard (Generium Pharmaceutical)
11.2.1 Pharmstandard (Generium Pharmaceutical) Company Information
11.2.2 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered
11.2.3 Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pharmstandard (Generium Pharmaceutical) Main Business Overview
11.2.5 Pharmstandard (Generium Pharmaceutical) Latest Developments
11.3 Sanofi S.A./Sanofi Pasteur Ltd.
11.3.1 Sanofi S.A./Sanofi Pasteur Ltd. Company Information
11.3.2 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered
11.3.3 Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi S.A./Sanofi Pasteur Ltd. Main Business Overview
11.3.5 Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments
11.4 Statens Serum Institut (SSI)
11.4.1 Statens Serum Institut (SSI) Company Information
11.4.2 Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered
11.4.3 Statens Serum Institut (SSI) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Statens Serum Institut (SSI) Main Business Overview
11.4.5 Statens Serum Institut (SSI) Latest Developments
11.5 Autoimmun Diagnostika (AID) GmbH
11.5.1 Autoimmun Diagnostika (AID) GmbH Company Information
11.5.2 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered
11.5.3 Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Autoimmun Diagnostika (AID) GmbH Main Business Overview
11.5.5 Autoimmun Diagnostika (AID) GmbH Latest Developments
11.6 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.
11.6.1 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Company Information
11.6.2 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered
11.6.3 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business Overview
11.6.5 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments
11.7 Haikou VTI Biological Institute (Vaccine Technologies, Inc.)
11.7.1 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Company Information
11.7.2 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered
11.7.3 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business Overview
11.7.5 Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments
11.8 Immunoshop India Pvt. Ltd.
11.8.1 Immunoshop India Pvt. Ltd. Company Information
11.8.2 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered
11.8.3 Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Immunoshop India Pvt. Ltd. Main Business Overview
11.8.5 Immunoshop India Pvt. Ltd. Latest Developments
11.9 Qiagen N.V.
11.9.1 Qiagen N.V. Company Information
11.9.2 Qiagen N.V. Latent TB Infection Testing Product Offered
11.9.3 Qiagen N.V. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Qiagen N.V. Main Business Overview
11.9.5 Qiagen N.V. Latest Developments
11.10 Quest Diagnostics, Inc. (Oxford Immunotec Global plc)
11.10.1 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Company Information
11.10.2 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered
11.10.3 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business Overview
11.10.5 Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments
11.11 SD Biosensor, Inc.
11.11.1 SD Biosensor, Inc. Company Information
11.11.2 SD Biosensor, Inc. Latent TB Infection Testing Product Offered
11.11.3 SD Biosensor, Inc. Latent TB Infection Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 SD Biosensor, Inc. Main Business Overview
11.11.5 SD Biosensor, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Latent TB Infection Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Major Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Latent TB Infection Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 7. Latent TB Infection Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 10. Global Latent TB Infection Testing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Latent TB Infection Testing Revenue Market Share by Player (2019-2024)
Table 12. Latent TB Infection Testing Key Players Head office and Products Offered
Table 13. Latent TB Infection Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Latent TB Infection Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Latent TB Infection Testing Market Size Market Share by Regions (2019-2024)
Table 18. Global Latent TB Infection Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Latent TB Infection Testing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Latent TB Infection Testing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Latent TB Infection Testing Market Size Market Share by Country (2019-2024)
Table 22. Americas Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 24. Americas Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 26. APAC Latent TB Infection Testing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Latent TB Infection Testing Market Size Market Share by Region (2019-2024)
Table 28. APAC Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 30. APAC Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 32. Europe Latent TB Infection Testing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Latent TB Infection Testing Market Size Market Share by Country (2019-2024)
Table 34. Europe Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 36. Europe Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Latent TB Infection Testing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Latent TB Infection Testing
Table 45. Key Market Challenges & Risks of Latent TB Infection Testing
Table 46. Key Industry Trends of Latent TB Infection Testing
Table 47. Global Latent TB Infection Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Latent TB Infection Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Latent TB Infection Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Latent TB Infection Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 52. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered
Table 53. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business
Table 55. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments
Table 56. Pharmstandard (Generium Pharmaceutical) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 57. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered
Table 58. Pharmstandard (Generium Pharmaceutical) Main Business
Table 59. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pharmstandard (Generium Pharmaceutical) Latest Developments
Table 61. Sanofi S.A./Sanofi Pasteur Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 62. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered
Table 63. Sanofi S.A./Sanofi Pasteur Ltd. Main Business
Table 64. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments
Table 66. Statens Serum Institut (SSI) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 67. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered
Table 68. Statens Serum Institut (SSI) Main Business
Table 69. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Statens Serum Institut (SSI) Latest Developments
Table 71. Autoimmun Diagnostika (AID) GmbH Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 72. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered
Table 73. Autoimmun Diagnostika (AID) GmbH Main Business
Table 74. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Autoimmun Diagnostika (AID) GmbH Latest Developments
Table 76. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 77. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered
Table 78. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business
Table 79. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments
Table 81. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 82. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered
Table 83. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business
Table 84. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments
Table 86. Immunoshop India Pvt. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 87. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered
Table 88. Immunoshop India Pvt. Ltd. Main Business
Table 89. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Immunoshop India Pvt. Ltd. Latest Developments
Table 91. Qiagen N.V. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 92. Qiagen N.V. Latent TB Infection Testing Product Offered
Table 93. Qiagen N.V. Main Business
Table 94. Qiagen N.V. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Qiagen N.V. Latest Developments
Table 96. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 97. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered
Table 98. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business
Table 99. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments
Table 101. SD Biosensor, Inc. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 102. SD Biosensor, Inc. Latent TB Infection Testing Product Offered
Table 103. SD Biosensor, Inc. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. SD Biosensor, Inc. Main Business
Table 105. SD Biosensor, Inc. Latest Developments
Table 1. Latent TB Infection Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Mantoux Test / Tuberculin Skin Test (TST)
Table 3. Major Players of Interferon-Gamma Release Assay (IGRA)
Table 4. Latent TB Infection Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 7. Latent TB Infection Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 10. Global Latent TB Infection Testing Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Latent TB Infection Testing Revenue Market Share by Player (2019-2024)
Table 12. Latent TB Infection Testing Key Players Head office and Products Offered
Table 13. Latent TB Infection Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Latent TB Infection Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Latent TB Infection Testing Market Size Market Share by Regions (2019-2024)
Table 18. Global Latent TB Infection Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Latent TB Infection Testing Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Latent TB Infection Testing Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Latent TB Infection Testing Market Size Market Share by Country (2019-2024)
Table 22. Americas Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 24. Americas Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 26. APAC Latent TB Infection Testing Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Latent TB Infection Testing Market Size Market Share by Region (2019-2024)
Table 28. APAC Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 30. APAC Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 32. Europe Latent TB Infection Testing Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Latent TB Infection Testing Market Size Market Share by Country (2019-2024)
Table 34. Europe Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 36. Europe Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Latent TB Infection Testing Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Latent TB Infection Testing Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Latent TB Infection Testing Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Latent TB Infection Testing
Table 45. Key Market Challenges & Risks of Latent TB Infection Testing
Table 46. Key Industry Trends of Latent TB Infection Testing
Table 47. Global Latent TB Infection Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Latent TB Infection Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Latent TB Infection Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Latent TB Infection Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 52. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Product Offered
Table 53. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Main Business
Table 55. Endo International plc (Par Sterile Products, LLC/JHP Pharmaceuticals, LLC) Latest Developments
Table 56. Pharmstandard (Generium Pharmaceutical) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 57. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Product Offered
Table 58. Pharmstandard (Generium Pharmaceutical) Main Business
Table 59. Pharmstandard (Generium Pharmaceutical) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pharmstandard (Generium Pharmaceutical) Latest Developments
Table 61. Sanofi S.A./Sanofi Pasteur Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 62. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Product Offered
Table 63. Sanofi S.A./Sanofi Pasteur Ltd. Main Business
Table 64. Sanofi S.A./Sanofi Pasteur Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi S.A./Sanofi Pasteur Ltd. Latest Developments
Table 66. Statens Serum Institut (SSI) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 67. Statens Serum Institut (SSI) Latent TB Infection Testing Product Offered
Table 68. Statens Serum Institut (SSI) Main Business
Table 69. Statens Serum Institut (SSI) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Statens Serum Institut (SSI) Latest Developments
Table 71. Autoimmun Diagnostika (AID) GmbH Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 72. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Product Offered
Table 73. Autoimmun Diagnostika (AID) GmbH Main Business
Table 74. Autoimmun Diagnostika (AID) GmbH Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Autoimmun Diagnostika (AID) GmbH Latest Developments
Table 76. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 77. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Product Offered
Table 78. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Main Business
Table 79. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Latest Developments
Table 81. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 82. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Product Offered
Table 83. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Main Business
Table 84. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Haikou VTI Biological Institute (Vaccine Technologies, Inc.) Latest Developments
Table 86. Immunoshop India Pvt. Ltd. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 87. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Product Offered
Table 88. Immunoshop India Pvt. Ltd. Main Business
Table 89. Immunoshop India Pvt. Ltd. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Immunoshop India Pvt. Ltd. Latest Developments
Table 91. Qiagen N.V. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 92. Qiagen N.V. Latent TB Infection Testing Product Offered
Table 93. Qiagen N.V. Main Business
Table 94. Qiagen N.V. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Qiagen N.V. Latest Developments
Table 96. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 97. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Product Offered
Table 98. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Main Business
Table 99. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Quest Diagnostics, Inc. (Oxford Immunotec Global plc) Latest Developments
Table 101. SD Biosensor, Inc. Details, Company Type, Latent TB Infection Testing Area Served and Its Competitors
Table 102. SD Biosensor, Inc. Latent TB Infection Testing Product Offered
Table 103. SD Biosensor, Inc. Latent TB Infection Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. SD Biosensor, Inc. Main Business
Table 105. SD Biosensor, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Latent TB Infection Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Latent TB Infection Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Latent TB Infection Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Latent TB Infection Testing Sales Market Share by Country/Region (2023)
Figure 8. Latent TB Infection Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Latent TB Infection Testing Market Size Market Share by Type in 2023
Figure 10. Latent TB Infection Testing in Hospitals
Figure 11. Global Latent TB Infection Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Latent TB Infection Testing in Public and Student Health
Figure 13. Global Latent TB Infection Testing Market: Public and Student Health (2019-2024) & ($ Millions)
Figure 14. Latent TB Infection Testing in Physician Offices and Clinics
Figure 15. Global Latent TB Infection Testing Market: Physician Offices and Clinics (2019-2024) & ($ Millions)
Figure 16. Latent TB Infection Testing in Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
Figure 17. Global Latent TB Infection Testing Market: Others (Military, Correctional Facilities, Chronic Care Homes, and Others) (2019-2024) & ($ Millions)
Figure 18. Global Latent TB Infection Testing Market Size Market Share by Application in 2023
Figure 19. Global Latent TB Infection Testing Revenue Market Share by Player in 2023
Figure 20. Global Latent TB Infection Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Latent TB Infection Testing Value Market Share by Country in 2023
Figure 26. United States Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Latent TB Infection Testing Market Size Market Share by Region in 2023
Figure 31. APAC Latent TB Infection Testing Market Size Market Share by Type in 2023
Figure 32. APAC Latent TB Infection Testing Market Size Market Share by Application in 2023
Figure 33. China Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Latent TB Infection Testing Market Size Market Share by Country in 2023
Figure 40. Europe Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 63. China Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 67. India Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 70. France Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global Latent TB Infection Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Latent TB Infection Testing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Latent TB Infection Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Latent TB Infection Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Latent TB Infection Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Latent TB Infection Testing Sales Market Share by Country/Region (2023)
Figure 8. Latent TB Infection Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Latent TB Infection Testing Market Size Market Share by Type in 2023
Figure 10. Latent TB Infection Testing in Hospitals
Figure 11. Global Latent TB Infection Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Latent TB Infection Testing in Public and Student Health
Figure 13. Global Latent TB Infection Testing Market: Public and Student Health (2019-2024) & ($ Millions)
Figure 14. Latent TB Infection Testing in Physician Offices and Clinics
Figure 15. Global Latent TB Infection Testing Market: Physician Offices and Clinics (2019-2024) & ($ Millions)
Figure 16. Latent TB Infection Testing in Others (Military, Correctional Facilities, Chronic Care Homes, and Others)
Figure 17. Global Latent TB Infection Testing Market: Others (Military, Correctional Facilities, Chronic Care Homes, and Others) (2019-2024) & ($ Millions)
Figure 18. Global Latent TB Infection Testing Market Size Market Share by Application in 2023
Figure 19. Global Latent TB Infection Testing Revenue Market Share by Player in 2023
Figure 20. Global Latent TB Infection Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Latent TB Infection Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas Latent TB Infection Testing Value Market Share by Country in 2023
Figure 26. United States Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Latent TB Infection Testing Market Size Market Share by Region in 2023
Figure 31. APAC Latent TB Infection Testing Market Size Market Share by Type in 2023
Figure 32. APAC Latent TB Infection Testing Market Size Market Share by Application in 2023
Figure 33. China Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Latent TB Infection Testing Market Size Market Share by Country in 2023
Figure 40. Europe Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Latent TB Infection Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Latent TB Infection Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 63. China Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 67. India Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 70. France Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Latent TB Infection Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global Latent TB Infection Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Latent TB Infection Testing Market Size Market Share Forecast by Application (2025-2030)
